A mathematical framework to determine the temporal sequence of somatic genetic events in cancer
- 23 September 2010
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (41) , 17604-17609
Abstract
Human cancer is caused by the accumulation of genetic alterations in cells. Of special importance are changes that occur early during malignant transformation because they may result in oncogene addiction and represent promising targets for therapeutic intervention. Here we describe a computational approach, called Retracing the Evolutionary Steps in Cancer (RESIC), to deduce the temporal sequence of genetic events during tumorigenesis from cross-sectional genomic data of tumors at their fully transformed stage. When applied to a dataset of 70 advanced colorectal cancers, our algorithm accurately predicts the sequence of APC , KRAS , and TP53 mutations previously defined by analyzing tumors at different stages of colon cancer formation. We further validate the method with glioblastoma and leukemia sample data and then apply it to complex integrated genomics databases, finding that high-level EGFR amplification appears to be a late event in primary glioblastomas. RESIC represents the first evolutionary mathematical approach to identify the temporal sequence of mutations driving tumorigenesis and may be useful to guide the validation of candidate genes emerging from cancer genome surveys.Keywords
This publication has 27 references indexed in Scilit:
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood, 2009
- Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in GliomagenesisCancer Cell, 2009
- Acquired mutations in TET2 are common in myelodysplastic syndromesNature Genetics, 2009
- Mutation inTET2in Myeloid CancersNew England Journal of Medicine, 2009
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesisProceedings of the National Academy of Sciences, 2009
- Many faces of Ras activationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
- Functional Copy-Number Alterations in CancerPLOS ONE, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Assessing the significance of chromosomal aberrations in cancer: Methodology and application to gliomaProceedings of the National Academy of Sciences, 2007
- Role of JAK2 in the pathogenesis and therapy of myeloproliferative disordersNature Reviews Cancer, 2007